One Shot Wonder: A Vaccine Against All Coronaviruses

IEEE Pulse
|December 14, 2020
PubMed

Insights

Researchers are developing a pan-coronavirus vaccine for broad protection against current and future coronaviruses, offering a proactive approach beyond individual outbreak responses.

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • The ongoing coronavirus disease 2019 (COVID-19) pandemic highlights the urgent need for effective vaccines.
  • Current vaccine development strategies often focus on specific viral strains, requiring rapid adaptation after outbreaks.

Purpose of the Study:

  • To explore the development of a universal vaccine offering protection against a wide range of coronaviruses.
  • To shift from reactive vaccine development to a proactive strategy against potential future coronavirus threats.

Main Methods:

  • Investigating conserved viral targets across the coronavirus family.
  • Designing vaccine platforms capable of eliciting broad-spectrum immune responses.

Main Results:

  • Identification of potential conserved epitopes suitable for a pan-coronavirus vaccine.
  • Preclinical data suggesting the feasibility of broad-acting coronavirus vaccine candidates.

Conclusions:

  • A pan-coronavirus vaccine represents a promising strategy to enhance global preparedness for future pandemics.
  • This approach could provide long-term protection against emerging and re-emerging coronavirus threats.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
49.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
658
Cross-reactivity00:42

Cross-reactivity

Overview
32.2K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.3K
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
316
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
441